A simple and minimally invasive skin biopsy could help diagnose Parkinson’s disease and other progressive nervous system disorders at the earliest stages, scientists say. The test looks for ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

Recent scientific discoveries are challenging traditional views of Parkinson’s disease, suggesting that this neurological condition might actually begin in an unexpected place, the digestive system.

is conducting a Phase III trial to see whether a small molecule known as buntanetap can inhibit the formation of toxic alpha-synuclein clumps in the brains of early-stage Parkinson’s patients.

The Eagles are shaking up their live show. The shift comes as guitarist Steuart Smith announced a struggle with Parkinson’s ...

While this research is still in its early stages, it represents something valuable: hope. For the millions of people affected by Parkinson’s disease worldwide, every new discovery is a step ...

Roche said a Parkinson's disease experimental drug missed its primary goal in a mid-stage trial, the second setback this week for candidate treatments for the neurodegenerative condition.

“Up to 80% of patients with PD eventually develop Parkinson disease dementia (PDD ... in [mild cognitive impairment] and PDD at all stages increases disability, diminishes function, and ...